Referenser till artikeln "Bröstcancer och relaterade behandlingar"

2) Shora, N. ”Double Jeopardy – The Link Between Insulin and Estrogen…” HealthLeader, 2005-11-01, University of Texas Health Science Center.
3) Northrup, Christiane. Women’s Bodies, Women’s Wisdom.
4) Vliet, Elizabeth. Screaming To Be Heard.
5) Lybeck-Kockum, C. ”Svenska kvinnor riskerar bröstcancer helt i onödan.” DN, 2009-05-13.
6) Gofman, John. Radiation from Medical Procedures in the Pathogenesis of Cancer and Ischemic Heart Disease. Committee Nuclear Responsibility, 1999.
7) Swift, M., Lukin, J.L. ”Breast Cancer Incidence and the Effect of Cigarette Smoking in Heterozygous Carriers of Mutations in the Ataxia-Telangiectasia Gene.” Cancer Epidemiol Biomarkers Prev. 2008-11, 17(11):3188-92.
8) Bridges, B. A., Arlett, C. F. ”Risk of breast cancer in ataxia-telangiectasia.” N. Engl. J. Med. 1992, 326( 20): 1357.
9) Epstein, S., Bertell, R., Seamna, B. ”Danger and Unreliability of Mammography <> .” International Journal of Health Services, 2001, vol.31, nr.3, sid.605-615.
10) Jørgensen KJ, Gøtzsche PC. ”Ärlig information om mammografiscreening, tack!” Läkartidningen 2009-10-26, nr 44.
11) USPSTF. ”Screening for Breast Cancer. Recommendation Statement.” 2009-11.
12) Sellman, S. ”Breast Cancer Awareness Month Story.” 2000-10-29,
13) Northrup, C. ”A much saner and less invasive approach.” Från Women’s health Wisdom e-news, 2009-10-01.
14) Mercola. J. ”Why Mammography is NOT an Effective Breast Cancer Screen.” 2008-12-04.
15) Batt, Sharon. ”Cancer, Inc.” Sierra Magazine, 1999.
16) Fisher B. et al. ”Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.” Journal of the National Cancer Institute 2005; 97(22):1652–1662.
17) Li, Cl. et al. ”Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.” Cancer Research, 2009-09-01;69(17):6865–70
18) Tuft’s University. ”Are Environmental Toxins Causing Breast Cancer?” Från Tuft’s E-news, 2002-10-28,
19) Bakker A, et al. ”Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients.” Ann Oncol. 1998, 9:1331-7;
20) Weijl N.I., Elsendoorn T.J., Lentjes E.G., et al. ”Supplementation with
antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatinbased chemotherapy: a randomised, double-blind, placebo-controlled study.” Eur J Cancer. 2004;40:1713-23.
21) Semba, D.K. et al.“Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women.” Nutrition Research vol. 29, sid 525–530
22) ScienceDaily. ”Vitamin D Found To Stimulate A Protein That Inhibits The Growth Of Breast Cancer Cells.” 2009-02-05,
23) Derry, D. ”Breast Cancer, Tamoxifen, Thyroid & Weight Loss.”
24) Auborn, K.J. et al. ”Indole-3-Carbinol Is a Negative Regulator of Estrogen.” J. Nutr. 2003-07, 133:2470S-2475S.
25) Bell MC, Crowley-Nowick P, Bradlow HL, et al. #Placebo-controlled trial of indole-3-carbinol in the treatment of CIN.” Gynecol Oncol. 2000,78:123-9.
26) Robey IF, Baggett BK, Kirkpatrick ND, et al. ”Bicarbonate increases tumor pH and inhibits spontaneous metastases.” Cancer Res. 2009,69:2260-2268.
27) Crinnion, W.J. ”Maternal Levels of Xenobiotics that Affect Fetal Development and Childhood Health.” Alternative Medicine Review 2009-09, vol.14 ,nr.3, s.219.